en | es | val
en · es · val
Close this search box.


ivo.es Dermatology

The IVO’s Dermatology Service provides comprehensive care in the field of Oncological Dermatology, through innovative diagnostic and treatment techniques for skin cancer, being pioneers in implementing techniques such as Mohs surgery, sentinel node in melanoma and photodynamic therapy.

The service is organized in three units: the Mohs Surgery Unit, the Photodynamic Therapy Unit and the Melanoma and Pigmented Lesions Unit

The dermatology department participates in and coordinates the Melanoma Committee, in which a multidisciplinary team of professionals defines the best personalised therapeutic strategy for each patient on a weekly basis

The service is organised into three units

The Mohs Surgery Unit

The Mohs Surgery Unit has positioned the IVO as national reference centre for the treatment of cutaneous carcinomas, being the first centre in Spain to introduce this technique in hospitals in 1993. This specialized micrographic Mohs surgery technique achieves high cure rates in complex conditions where conventional surgery has not obtained satisfactory results. It is the most effective technique for non-melanoma skin cancer. It involves the removal of the skin tumours at the same time as an analysis of the entire intraoperative surgical margin is carried out, to ensure the complete removal of the tumour.

Photodynamic Therapy Unit

This pioneering method in Spain makes it possible to treat cutaneous cancer and precancerous cutaneous lesions without surgery.

Melanoma and Pigmented Lesions Unit

The Melanoma and Pigmented Lesions Unit provides treatment and follow-up of patients who suffer from these conditions. This unit was a pioneer in the use of the most advanced techniques for early diagnosis in patients at high risk through the use of digital dermoscopy. It is staffed by specialists that are exclusively dedicated to this type of patients, allowing highly specialized monitoring.

The unit is specialized in the study of histological diagnosis, epidemiology, molecular biology of melanoma, genetic predisposition, and the immune response in melanoma. It has developed a wide variety of research projects upon these subjects, both in-house and in collaboration with both international (National Cancer Institute, German Cancer Research Center, DeCODE Genetics, Queensland Melanoma Project, GenoMEL, BioGenoMEL) and Spanish (Registro Nacional de Melanoma de la Academia Española de Dermatología y Venereología) work groups, all of which are at the forefront of research in melanoma.

Skin Cancer



Dermatofibrosarcoma protuberans

The IVO’s Dermatology Service has ample experience in the treatment of dermatofibrosarcoma protuberans through delayed Mohs surgery, making it a global reference centre in the diagnosis and management of this kind of skin tumour, with experience garnered from the treatment of more than 200 cases, one of the largest series in the world.

European-Funded Research Projects

Next-generation sequencing for identifying the molecular features of cutaneous melanoma according to the aetiopathogenic pathway of development and their potential clinical relevance

Massive sequencing in non-acral sporadic cutaneous melanoma without known risk factors. Molecular characterisation and mutational load

National Medical Residency System

The Instituto Valenciano de Oncología Foundation has an accredited position for specialised medical training in Medical-Surgical Dermatology and Venereology.

Dermatology Service Medical Team

Head of Service

Dr. Onofre Sanmartín Jiménez

Heads of Section

Dr. Eduardo Nagore Enguídanos

Associated Doctors

Dr. Beatriz Llombart Cussac
Dr. Celia Requena Caballero
Dr. Carlos Serra Guillén

Skin Cancer News

No posts found!